Multiple sclerosis, a chronic neurological disorder that affects an estimated 2.8 million people worldwide, is being diagnosed increasingly in seemingly healthy adults in midlife, neurologists say — and lifestyle factors appear to play a role.
High-profile cases spotlight shifting patterns
The recent public diagnoses of well-known figures have drawn attention to a changing picture of the disease. Actress Christina Applegate received an MS diagnosis at 49, and actor Tom King has discussed a diagnosis at 62. Actress Selma Blair, who is in her 50s, has also been publicly managing the condition. Those stories underscore a trend clinicians describe as an accumulation of risks that eventually tip the scale toward symptomatic disease.
Experts describe a cumulative risk model
Neurologists emphasize that developing MS is rarely the result of a single event. As Dr. Erin Longbrake, a neurologist specializing in MS, put it:
"Developing MS is not a one-hit type of thing. It's all of the little pebbles being added onto the scale, and it finally tips over into disease."
That explanation frames MS as a condition influenced by multiple interacting factors, including genetic susceptibility and lifestyle or environmental contributors.
What the public should know
While the exact set of lifestyle factors is not itemized in the source material, the coverage highlights several practical takeaways for people tracking neurological health or supporting loved ones with MS:
- Awareness: Symptoms can begin subtly — balance issues, numbness, tingling — and may be mistaken for fatigue or other conditions.
- Early evaluation: Persistent or progressive neurological symptoms warrant medical assessment by a neurologist.
- Visibility helps: Public conversations from celebrities have pushed MS into broader awareness, which can encourage diagnosis and support.
| Person | Age at publicized diagnosis |
|---|---|
| Christina Applegate | 49 |
| Tom King | 62 |
| Selma Blair | in her 50s |
The personal accounts shared by Applegate and others also describe how the disease can progress quickly, with symptoms moving from subtle sensory changes to more debilitating problems such as leg weakness, neuropathic pain, vision disturbances and gastrointestinal effects. Applegate has spoken candidly about losing physical abilities and the impact on her career, and she has said she has not reached acceptance of her diagnosis.
Consequences for care and awareness
The shift toward more midlife diagnoses has implications for clinicians and the public. Greater awareness may prompt earlier evaluation and intervention, while shining a spotlight on the multifactorial nature of MS may influence research priorities and prevention discussions. As public figures share their journeys, they also increase visibility for support services and advocacy efforts that assist people living with the disease.
For anyone experiencing persistent neurological symptoms, specialists recommend seeking medical attention to explore causes and management options. Increased attention to lifestyle and environmental contributors may spur more research into how best to reduce risk and support those affected.
Key details: MS affects roughly 2.8 million people globally; publicized cases include diagnoses at ages 49 and 62, and accounts emphasize gradual accumulation of risk factors leading to disease onset.
